catheter onto which the valve is hand crimped. The level of expansion of the valve is determined by the size of the outer balloon used for inflation (range, 18-22 mm). The balloon and Melody valve are covered by a movable sleeve that is retracted before positioning and deployment with 22F profile that could easily be advanced through a 24F Ascendra-2 transapical sheath (Ascendra Inc, Reston, VA) originally designed for Edwards-XT transcatheter aortic valve implantation with its radiopaque markers and a reliable hemostatic seal.
The femoral vessels were accessed for transvenous pacing and an aortic root marker pigtail catheter. The working angle was determined to be perpendicular to the Mitroflow ring (Figures 2 and 3 ). To avoid unequal valve expansion and to verify the true inner diameter of Mitroflow, we predilated the stenotic valve with a Nucleus 18-mm balloon (NuMed Inc, Hopkington, NY; Figure 4 ). After the valvuloplasty, the Melody delivery system was introduced via the Ascendra-2 sheath and positioned in a 50:50 position through the valve 
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Discussion
Use of transcatheter aortic valve implantation in patients after surgical aortic valve replacement has previously been reported. 1, 2 The 26-mm CoreValve is suitable for native 
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annular sizes of 20 to 23 mm; the Edwards 23-mm valve is suitable for minimal diameters of 18 to 21 mm. Therefore, these valves raise considerable concerns when treating patients with degenerated surgical valves with outer diameters of 19 to 21 mm, 3 and the results of these procedures are highly unanticipated. The Melody valve was designed primarily for percutaneous transvenous implantation into pulmonary artery conduits, predominantly in pediatric and adolescent populations. The valved vein segment is sutured to a 28-mm-long platinumiridium stent, can be crimped to a diameter of 6 mm and re-expanded up to 22 mm, and is competent over a range of 16 to 22 mm.
To the best of our knowledge, there are no previous reports describing transapical deployment of a Melody valve in a 19-mm degenerated aortic valve. Although it was designed for low-pressure pulmonary circulation, Hasan et al 4 recently described good-durability performance of the Melody valve in 30 patients in a high-pressure hemodynamic environment after a mean follow-up of 1 year.
Because our patient had patent grafts, we had little concern of coronary ostial occlusion, but a possible measure with no coronary grafts is to fenestrate the tissue from the outflow portion of the valve stent to allow flow to the aortic sinuses, as previously described. 4 In conclusion, transapical-transcatheter melody implantation may provide some resolution for very-high-risk surgical patients with degenerated small-diameter (19-21 mm) 
